* Meta-terms correspond to biological or medical specialty concerned with one or more keywords (or keywords hierarchies), qualifiers, or resource types. Other terms also benefit from this structure, when the topic warrants it, eg education. See the list.

Doc'CISMeF search for this specility :


Preferred Label : urology;

True Meta (CISMeF) : O;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-acces-derogatoire/avastin-r-25-mg-ml-solution-a-diluer-pour-perfusion
2025
false
false
false
France
French
Bevacizumab
drug information
guidelines for drug use
intravitreal injections
macular degeneration
Neovascular age-related macular degeneration

---
https://ansm.sante.fr/tableau-marr/icodextrine
2025
false
false
false
France
French
risk management
guidelines for drug use
peritoneal dialysis
blood glucose self-monitoring
Icodextrin
Blood glucose meter (physical object)
directory
patient education handout

---
https://www.has-sante.fr/jcms/p_3576306/fr/imfinzi-durvalumab-et-lynparza-olaparib-en-association-cancer-de-l-endometre
2025
false
false
false
France
evaluation of the transparency committee
olaparib
cancer
Imfinzi
endometrial neoplasms
durvalumab
Lynparza
endometrium
neoplasm, malignant
olaparib
association
olaparib
durvalumab
Endomet

---
https://www.has-sante.fr/jcms/p_3575605/fr/choix-et-durees-d-antibiotherapie-dans-les-infections-genitales-hautes-non-compliquees
2025
France
practice guideline
antibiotic therapy
reproductive tract infections
Infections
genital system, nos
infectious disease, nos
complication, nos
choice behavior

---
https://www.has-sante.fr/jcms/p_3577228/fr/cancer-sein-colorectal-prostate-l-activite-physique-pour-votre-sante
2025
France
patient education handout
paper
prostate cancer
prostate, nos
neoplasm, malignant
Colorectal Cancer
physics
exercise
breast neoplasms
prostatism, nos
malignant neoplasm colon/rectum
malignant neoplasm prostate
health
prostatic neoplasms
breast cancer
colorectal neoplasms

---
https://www.has-sante.fr/jcms/p_3568298/fr/vapro-plus-pocket
2025
France
health technology assessment
urinary catheters
probing, nos
urinary catheter
urinary catheterization
catheterization

---
https://www.has-sante.fr/jcms/p_3568301/fr/vapro-plus
2025
France
health technology assessment
probing, nos
urinary catheterization
catheterization
urinary catheter
urinary catheters

---
https://www.has-sante.fr/jcms/p_3578473/fr/gynecare-tvt-exact
2025
France
health technology assessment
suburethral slings
urethra, nos
implant, nos

---
https://www.has-sante.fr/jcms/p_3578476/fr/cyrene-et-cyrene-premium
2025
France
health technology assessment
implant, nos
suburethral slings
urethra, nos

---
https://www.has-sante.fr/jcms/p_3578479/fr/obturateur-gynecare-tvt
2025
France
health technology assessment
urethra, nos
complete obstruction
implant, nos
suburethral slings

---
https://www.has-sante.fr/jcms/p_3578482/fr/aris
2025
France
health technology assessment
urethra, nos
suburethral slings
implant, nos

---
https://www.has-sante.fr/jcms/p_3578485/fr/gynecare-tvt
2025
France
health technology assessment
suburethral slings
implant, nos
urethra, nos

---
https://www.has-sante.fr/jcms/p_3585759/fr/balversa-erdafitinib-carcinome-urothelial
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
erdafitinib
Product containing only erdafitinib in oral dose form (medicinal product form)
administration, oral
FGFR Inhibitor
receptors, fibroblast growth factor
adult
Unresectable Urothelial Carcinoma
Metastatic Urothelial Carcinoma
FGFR3 Gene Alteration Positive
receptor, fibroblast growth factor, type 3
Alteration of genetic material (finding)
evaluation of the transparency committee
Balversa
erdafitinib

---
https://www.cochrane.org/fr/CD014966/RENAL_quels-sont-les-effets-du-sexe-et-du-genre-sur-les-criteres-de-jugement-apres-une-greffe-de-rein
2025
United Kingdom
review of literature
french abstract
judgement, nos
kidney
judgment
gender identity
kidney transplantation
sex
transplant of kidney, nos
gender

---
https://www.has-sante.fr/jcms/p_3586464/fr/cyrene
2025
France
health technology assessment
urethra, nos
suburethral slings
implant, nos

---
https://minerva-ebp.be/FR/Article/2417
2025
Belgium
critical appraisal or critical reading
antibiotics
urinary tract infections
prescription, nos
anti-bacterial agents
women
principal
primary health care
urinary tract infectious disease, nos
antibiotic, nos
nursing
urinary tract infections
primary health care

---
https://www.inserm.fr/dossier/insuffisance-renale/
2025
France
popular works
mechanics
kidney
kidney, nos
insufficiency
renal insufficiency

---
https://www.has-sante.fr/jcms/p_3591609/fr/swing-band-sb3-et-swing-band-sb4
2025
France
health technology assessment
urethra, nos
suburethral slings
implant, nos

---
https://ansm.sante.fr/informations-de-securite/emblaveo-aztreonam-avibactam-1-5-g-0-5-g-poudre-pour-solution-a-diluer-pour-perfusion-risque-potentiel-de-flacons-fissures-ou-casses
2025
false
false
false
France
French
pharmacovigilance note

---
https://www.has-sante.fr/jcms/p_3595631/fr/swing-band-sb3-et-swing-band-sb4
2025
France
health technology assessment
implant, nos
suburethral slings
urethra, nos

---
https://www.has-sante.fr/jcms/p_3594124/fr/kranus-edera
2025
France
health technology assessment
attention
functional disorder, nos
therapeutics
erectile dysfunction

---
https://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Oncologie/EC_Cancer_prostate_biomarqueurs_INESSS.pdf
2025
Canada
review of literature
tumor burden
malignant neoplasm prostate
Biomarkers
disease
persons
prostatism, nos
prostate cancer
prostate, nos
neoplasm, malignant
patient care management
prostatic neoplasms

---
https://www.ema.europa.eu/en/medicines/human/EPAR/balversa
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
erdafitinib
erdafitinib
erdafitinib
drug approval
europe
Balversa
Metastatic Urothelial Carcinoma
Unresectable Urothelial Carcinoma
urologic neoplasms
adult
urologic neoplasms
FGFR3 Gene Alteration Positive
administration, oral
continuity of patient care
Tyrosine Kinase Inhibitors
Tyrosine Kinase Inhibitors
FGFR Inhibitor
FGFR Inhibitor
risk management
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
Female of Childbearing Potential
antineoplastic agents
antineoplastic agents
drug evaluation, preclinical

---
https://minerva-ebp.be/FR/Article/2428
2025
Belgium
critical appraisal or critical reading
prostate, nos
magnetic resonance imaging, nos
magnetic resonance imaging
lesion, nos
prostate cancer
wounds and injuries
cancer screening
screening for cancer
prostatic neoplasms
due to
early detection of cancer
malignant neoplasm prostate
prostatism, nos

---
https://www.has-sante.fr/jcms/p_3599560/fr/i-stop
2025
France
health technology assessment
implant, nos
suburethral slings
urethra, nos

---
https://ansm.sante.fr/tableau-acces-derogatoire/balversa-erdafitinib
2025
false
false
false
France
French
drug information
erdafitinib
administration, oral
erdafitinib

---
https://ansm.sante.fr/actualites/amoxicilline-des-recommandations-pour-contribuer-a-garantir-la-couverture-des-besoins-des-patients
2025
false
false
false
France
French
amoxicillin
guidelines for drug use
amoxicillin
administration, oral
infant
child
amoxicillin
amoxicillin-potassium clavulanate combination
amoxicillin-potassium clavulanate combination
amoxicillin and beta-lactamase inhibitor

---
https://ansm.sante.fr/tableau-acces-derogatoire/enfortumab-vedotin-padcev
2025
false
false
false
France
French
drug information
insurance, health, reimbursement
enfortumab vedotin
enfortumab vedotin
Locally Advanced Urothelial Carcinoma
carcinoma, transitional cell
urologic neoplasms
Metastatic Urothelial Carcinoma
neoplasm metastasis
Refractory Urothelial Carcinoma
infusions, intravenous
antineoplastic agents
antineoplastic combined chemotherapy protocols
pembrolizumab
Enfortumab Vedotin/Pembrolizumab Regimen
Unresectable Urothelial Carcinoma

---
https://www.has-sante.fr/jcms/p_3576072/fr/padcev-enfortumab-vedotin-carcinome-urothelial
2025
false
false
false
France
Urothelial Carcinoma
evaluation of the transparency committee
enfortumab vedotin
carcinoma
enfortumab vedotin

---
https://minerva-ebp.be/FR/Analysis/864
2024
Belgium
critical appraisal or critical reading
infection control
Cranberry
Dental Base
What Month is it
urinary tract infections
urinary tract infections
Baseline
Base of the Prostate
Nucleotide
Cranberry Flavor
vaccinium macrocarpon
Frangula californica
Prevention Study
Single-Stranded DNA Cytosine Deaminase
Baseline Epoch
Atherogenic Index of Plasma
AICDA wt Allele
Assistance
Phytolacca americana
Core Device
Without Help
Acute Interstitial Pneumonia
AIP Gene
AH Receptor-Interacting Protein
cranberry
base, nos
Core Specimen
With Some Help
Preparation
urinary tract infectious disease, nos
Preventive Intervention
Prevention
reference standards
Urinary Tract Infection

---
https://www.rheuma-net.ch/fr/doc/cyclophosphamid-1/viewdocument/348
2024
Switzerland
guideline
cyclophosphamide
cyclophosphamide
Background Treatment
Cyclophosphamide

---
https://www.has-sante.fr/jcms/p_3519904/fr/imfinzi-durvalumab-et-lynparza-olaparib-en-association-cancer-de-l-endometre
2024
false
false
false
France
antineoplastic combined chemotherapy protocols
endometrial neoplasms
evaluation of the transparency committee
durvalumab
olaparib

---
https://www.has-sante.fr/jcms/p_3519087/fr/sensura-mio
2024
France
health technology assessment
urinary tract, nos
Pouch
Twice
equipment and supplies, hospital
numismatics
Urinary System
MLXIPL wt Allele
Stomatocyte Count
Bag
urinary tract
urinary reservoirs, continent
ostomy collection bag
Pouch Dosing Unit
Stoma
Murine Urinary System
coins
Pouch Dosage Form Category

---
https://www.has-sante.fr/jcms/p_3519090/fr/sensura-mio
2024
France
health technology assessment
equipment and supplies, hospital
Stomatocyte Count
Murine Urinary System
Urinary System
Exhibit
Stoma
urinary tract, nos
stoma site, nos
urinary tract
Piece Unit
MLXIPL wt Allele

---
https://www.ema.europa.eu/en/medicines/human/EPAR/emblaveo
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
drug combinations
avibactam
avibactam
aztreonam
aztreonam
anti-bacterial agents
anti-bacterial agents
adult
beta-Lactamase Inhibitors
beta-Lactamase Inhibitors
intraabdominal infections
complicated intra-abdominal infections
Healthcare-Associated Pneumonia
pyelonephritis
Gram-Negative aerobic bacteria
Gram-Negative bacterial infections
infusions, intravenous
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
aztreonam and beta-lactamase inhibitor

---
https://www.has-sante.fr/jcms/p_3527216/fr/afinitor-everolimus-tumeurs-neuroendocrines-d-origine-pancreatique
2024
false
false
false
France
pancreatic neoplasms
treatment outcome
insurance, health, reimbursement
disease progression
adult
Metastatic Pancreatic Neuroendocrine Tumor
Unresectable Pancreatic Neuroendocrine Tumor
administration, oral
antineoplastic agents
everolimus
evaluation of the transparency committee
neuroendocrine tumors
Everolimus

---
https://dumas.ccsd.cnrs.fr/dumas-04630561
2024
France
dissertations, academic
nursing
principal
Biological Detection Test
Database
male, nos
Detection
Physical Examination
Assessment
urinary tract infections
Abnormal Virilization
detective
evaluation studies as topic
Masculine
self care
Primary Care
urinary tract infections
Algorithm
primary health care
databases as topic
Primary Data
algorithms
urinary tract infectious disease, nos
Urinary Tract Infection
Evaluation
base, nos
Source Data Not Available
Clinical Trial Source Data Documentation
Assessment
database
primary health care

---
https://www.cochrane.org/fr/CD013773/PROSTATE_effets-de-lablation-du-rein-en-association-avec-des-medicaments-chez-les-personnes-atteintes-dun
2024
United Kingdom
review of literature
french abstract
cancer of kidney
malignant neoplasm of kidney
drug therapy, combination
body parts
People
nephrectomy
disease
human body
Combination Drug Therapy
Renal Cell Carcinoma
persons
Other Body Part
Cancer Other
societies
neoplasm, malignant
excision, nos
Effect
Ablation Therapy
kidney neoplasms
drug action, nos
Spread

---
https://www.has-sante.fr/jcms/p_3530407/fr/cyclophosphamide-accord-cyclophosphamide-cancer-et-maladies-auto-immunes
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
Product containing only cyclophosphamide in parenteral dose form (medicinal product form)
precursor cell lymphoblastic Leukemia-Lymphoma
cyclophosphamide
transplantation conditioning
multiple myeloma
hodgkin disease
lymphoma, Non-Hodgkin
ovarian neoplasms
breast neoplasms
neoplasm metastasis
sarcoma, ewing
small cell lung carcinoma
bronchial neoplasms
neuroblastoma
lupus nephritis
Granulomatosis with Polyangiitis
myeloablative agonists
antineoplastic agents, alkylating
immunosuppressive agents
evaluation of the transparency committee
cyclophosphamide
autoimmune diseases

---
https://www.pedia-univ.fr/deuxieme-cycle/referentiel/nephrologie-chirurgie-urologique/proteinurie-syndrome-nephrotique-hematurie
2024
France
educational course
nephrotic syndrome, nos
Nephrotic Syndrome, CTCAE
Hematuria
proteinuria
Proteinuria, CTCAE 3.0
proteinuria syndrome, nos
Nephrotic Syndrome
Proteinuria
nephrotic syndrome
hematuria syndrome, nos
Hematuria, CTCAE
haematuria
hematuria

---
https://www.pedia-univ.fr/deuxieme-cycle/referentiel/nephrologie-chirurgie-urologique/troubles-miction
2024
France
educational course
Micronization
micturition
urination
urination disorders
Urination
Disease or Disorder

---
https://www.pedia-univ.fr/deuxieme-cycle/referentiel/infectiologie/infections-urinaires
2024
France
educational course
urinary tract infections
Urinary Tract Infection
urinary tract infectious disease, nos
urinary tract infections

---
https://www.pedia-univ.fr/deuxieme-cycle/referentiel/gastroenterologie-nutrition-chirurgie-abdomino-pelvienne/pathologies-courantes-region-inguino-scrotale-du-penis
2024
France
educational course
scrotum, nos
penis
Pathology
Penis
Murine Penis
Diseased
Clinical Trial Registry Identifier
penile diseases

---
https://www.has-sante.fr/jcms/p_3530995/fr/simulect-basiliximab-prevention-du-rejet-de-greffe-renale
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
transplantation, homologous
adult
adolescent
child
infant
Product containing precisely basiliximab 20 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Product containing precisely basiliximab 10 milligram/1 vial powder for conventional release solution for injection (clinical drug)
immunosuppressive agents
basiliximab
evaluation of the transparency committee
graft rejection
kidney transplantation
Basiliximab

---
https://www.has-sante.fr/jcms/p_3534502/fr/emblaveo-aztreonam/avibactam-infections-graves
2024
false
false
false
France
drug combinations
anti-bacterial agents
treatment outcome
insurance, health, reimbursement
avibactam
Avibactam Sodium
beta-Lactamase Inhibitors
aztreonam
intraabdominal infections
complicated intra-abdominal infections
Complicated intra-abdominal infection
Healthcare-Associated Pneumonia
pneumonia, ventilator-associated
pyelonephritis
urinary tract infections
Gram-Negative bacterial infections
aztreonam and beta-lactamase inhibitor
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3420797/fr/keytruda-pembrolizumab-cancer-du-sein
2024
false
false
false
France
evaluation of the transparency committee
breast neoplasms
pembrolizumab
breast cancer
pembrolizumab
Childhood Breast Carcinoma
Pembrolizumab
neoplasm, malignant
Male Breast Carcinoma
Keytruda
pembrolizumab

---
https://www.has-sante.fr/jcms/p_3535830/fr/cisplatine-hikma-cisplatine-oncologie
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
cisplatin
infusions, intravenous
antineoplastic agents
testicular neoplasms
ovarian neoplasms
urinary bladder neoplasms
neoplasm metastasis
Squamous Cell Carcinoma of Head and Neck
carcinoma, non-small-cell lung
uterine cervical neoplasms
evaluation of the transparency committee
cisplatin

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/modalites-optimales-dorganisation-et-de-prestation-des-soins-et-services-lies-a-la-cystectomie-radicale-au-quebec.html
2024
Canada
technical report
organizers, embryonic
organization
Health Care Delivery
Optimum
Care Of
Health Care Organization
delivery of health care
organizations
Radical Cystectomy
quebec
radical cystectomy
nursing
cystectomy

---
https://ansm.sante.fr/tableau-acces-derogatoire/keytruda-25-mg-ml-solution-a-diluer-pour-perfusion#
2024
false
false
false
France
French
drug information
triple negative breast neoplasms
pembrolizumab
pembrolizumab
guidelines for drug use
adult
Early Stage Triple-Negative Breast Carcinoma
Locally Advanced Triple-Negative Breast Carcinoma
inflammatory breast neoplasms
Antineoplastic Agents, Immunological
endometrial neoplasms
clear cell renal cell carcinoma
renal cell carcinoma at increased risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions
antineoplastic combined chemotherapy protocols
Enfortumab Vedotin/Pembrolizumab Regimen
Unresectable Urothelial Carcinoma
Metastatic Urothelial Carcinoma
urologic neoplasms
carcinoma

---
https://ansm.sante.fr/tableau-marr/tacrolimus
2024
false
false
false
France
French
risk management
tacrolimus
tacrolimus
administration, oral
guidelines for drug use
patient education handout
continuity of patient care
immunosuppressive agents

---
https://ansm.sante.fr/tableau-acces-derogatoire/lynparza-100-mg-et-150-mg-comprimes-pellicules
2024
false
false
false
France
French
drug information
olaparib
administration, oral
olaparib
breast neoplasms
HER2-Negative Breast Carcinoma

---
https://ansm.sante.fr/actualites/nulojix-belatacept-pour-la-greffe-de-rein-recommandations-temporaires-pour-garantir-la-continuite-des-soins
2024
false
false
false
France
French
guidelines for drug use
Abatacept

---
https://ansm.sante.fr/tableau-marr/eculizumab
2024
false
false
false
France
French
risk management
guidelines for drug use
eculizumab
eculizumab
continuity of patient care
drug monitoring
patient safety
sepsis
meningococcal infections
risk
vaccination
antibiotic prophylaxis
adult
child
infant
patients guideline
patient education handout
Drug-Related side effects and adverse reactions
meningococcal vaccines

---
https://publications.msss.gouv.qc.ca/msss/document-003313/
2024
false
false
false
Canada
technical report
urinary bladder cavity
antineoplastic agents
nursing care, nos
Methods
route of administration, nos
nursing care
nurse administrators
administration
administration, intravesical
protestantism
antineoplastic agent, nos
Administration

---
https://www.cochrane.org/fr/CD009508/CENTRALED_quelles-approches-sont-les-plus-efficaces-pour-traiter-les-fuites-involontaires-durine-chez-les
2024
false
true
false
United Kingdom
France
urinary incontinence
female
pelvic floor disorders
exercise therapy
treatment outcome
review of literature
french abstract

---
https://www.cochrane.org/fr/CD004925/RENAL_la-pose-dun-stent-prophylactique-de-routine-reduit-lincidence-de-complications-urologiques-majeures
2024
false
true
false
France
United Kingdom
stents
urinary tract infections
treatment outcome
Routine health maintenance
review of literature
french abstract
kidney transplantation

---
https://ansm.sante.fr/tableau-marr/atezolizumab
2024
false
false
false
France
French
atezolizumab
atezolizumab
atezolizumab
Drug-Related side effects and adverse reactions
risk management
drug information
patient education handout
Drug-Related side effects and adverse reactions
signs and symptoms
antineoplastic agents
antineoplastic agents
immune system diseases
immune system diseases
antibodies, monoclonal
antibodies, monoclonal

---
https://ansm.sante.fr/tableau-marr/pembrolizumab
2024
false
false
false
France
French
risk management
pembrolizumab
Infusion related reaction
immune system diseases
Drug-Related side effects and adverse reactions
patient education handout
pregnancy
continuity of patient care
drug monitoring
Antineoplastic Agents, Immunological
pembrolizumab
antibodies, monoclonal
antibodies, monoclonal, humanized

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/guides-dusage-optimal-sur-le-traitement-pharmacologique-des-itss.html
2024
false
Canada
French
practice guideline
adolescent
adult
syphilis
uterine cervicitis
urethritis
epididymitis
pelvic inflammatory disease
herpes genitalis
chlamydia infections
gonorrhea
condylomata acuminata

---
https://www.sggg.ch/fileadmin/user_upload/Dokumente/3_Fachinformationen/1_Expertenbriefe/Fr/84_Examen_urodynamique.pdf
2024
Switzerland
guideline
N
Newton
Medical Examination
No
Review
N Category
MATCH Arm EAY131-N
Tumor to Normal
Neither Agree or Disagree
Signal to Noise Ratio
expert opinion
Nano
urodynamics
Examination
expert testimony

---
https://www.cochrane.org/fr/CD011671/RENAL_utilisation-de-machines-perfusion-pour-preserver-les-reins-de-donneurs-decedes-avant-une
2024
United Kingdom
review of literature
french abstract
perfusion, nos
Kidney Donor
Subject Off Trial due to Death
donor of kidney for transplant
donors
Infusion Procedure
Machinery Heart Murmur
machine, nos
Infusion Method of Administration
condom
transplantation
condoms
kidney transplantation
Perfusion
Use
tissue donors
Transplantation
Chemotherapeutic Perfusion
Graft
Preservation
perfusion
Dead
Condom

---
https://minerva-ebp.be/FR/Article/2394
2024
Belgium
critical appraisal or critical reading
Improved
C-C Motif Chemokine 7
Single
Prostate-Specific antigen
screening for cancer
Unique
Prostate Specific Antigen Measurement
decline, mortality
cancer screening
specific
Fifteen
Screening for Prostate Cancer
Autonomic Nervous System
malignant neoplasm prostate
prostate, nos
Discrete
polysialic acid
Single
Decay
Overall
CCL7 wt Allele
Enhance
mortality
early detection of cancer
prostate cancer
Fogarty International Center
Specified
prostatic neoplasms

---
https://www.srlf.org/article/tazocilline-cefepime-reanimation-qui-fait-mieux
2024
France
critical appraisal or critical reading
Cefepime
Device Properties Domain
Reasoning
What Month is it
Dong Chinese
Resuscitation
Cefepime
Foundation for the Accreditation of Cellular Therapy
Doctor of Osteopathic Medicine
Better than Others
cefepime
resuscitation
Improved
Dominican Republic

---
https://www.cfp.ca/content/70/9/e129
2024
Canada
journal article
infectious disease, nos
urine
urine

---
https://minerva-ebp.be/FR/Analysis/877
2024
Belgium
critical appraisal or critical reading
diagnosis
prostatic neoplasms
no diagnosis
prostate cancer
prostate, nos
cancer screening
malignant neoplasm prostate
screening for cancer
early detection of cancer
magnetic resonance imaging, nos
role
magnetic resonance imaging

---
https://www.has-sante.fr/jcms/p_3544702/fr/i-stop
2024
France
evaluation studies
implant, nos
urethra, nos
suburethral slings

---
https://www.has-sante.fr/jcms/p_3545041/fr/energies-laser-en-urologie
2024
France
guideline
patient safety
solutions
urology
tool, nos
professional practice
solution, nos
has patient
laser

---
https://www.has-sante.fr/jcms/p_3546684/fr/keytruda-pembrolizumab-carcinome-urothelial
2024
false
false
false
France
urologic neoplasms
treatment outcome
insurance, health, reimbursement
antineoplastic combined chemotherapy protocols
Enfortumab Vedotin/Pembrolizumab Regimen
enfortumab vedotin
adult
Metastatic Urothelial Carcinoma
Unresectable Urothelial Carcinoma
pembrolizumab
evaluation of the transparency committee
carcinoma
pembrolizumab

---
https://www.has-sante.fr/jcms/p_3546650/fr/padcev-enfortumab-vedotin-carcinome-urothelial
2024
false
false
false
France
Enfortumab Vedotin/Pembrolizumab Regimen
treatment outcome
insurance, health, reimbursement
urologic neoplasms
antineoplastic combined chemotherapy protocols
pembrolizumab
Metastatic Urothelial Carcinoma
Unresectable Urothelial Carcinoma
adult
enfortumab vedotin
antineoplastic agents
evaluation of the transparency committee
carcinoma
enfortumab vedotin

---
https://www.has-sante.fr/jcms/p_3546934/fr/keytruda-pembrolizumab-cancer-du-rein-en-adjuvant
2024
false
false
false
France
Clear Cell Renal Cell Carcinoma
carcinoma, renal cell
treatment outcome
insurance, health, reimbursement
adult
Antineoplastic Agents, Immunological
pembrolizumab
Adjuvant Therapy
nephrectomy
risk
recurrence
evaluation of the transparency committee
pembrolizumab

---
https://www.has-sante.fr/jcms/p_3546280/fr/ultravist-iopromide-produit-de-contraste-iode
2024
false
false
false
France
iopromide
neoplasm staging
Tumor Size Measurement
breast neoplasms
evaluation of the transparency committee
iopromide
contrast media

---
https://www.has-sante.fr/jcms/p_3546286/fr/omnipaque-iohexol-produit-de-contraste-iode
2024
false
false
false
France
insurance, health, reimbursement
iohexol
breast neoplasms
Tumor Size Measurement
neoplasm staging
evaluation of the transparency committee
contrast media
iohexol

---
https://boutique.liguecancer.ch/files/kls/webshop/PDFs/francais/le-cancer-de-la-prostate-myths-et-realites.pdf
2024
Switzerland
patient education handout
prostatic neoplasms
malignant neoplasm prostate
prostate cancer
prostate, nos
prostatism, nos
neoplasm, malignant

---
https://www.irsst.qc.ca/publications-et-outils/publication-irsst/i/101218/n/dosage-triclopyr-tcpy-urine-uplc-ms-ms-apres-hydrolyse
2024
Canada
technical report
triclopyr
triclopyr
protestantism
urine
urine
hydrolysis

---
https://www.cochrane.org/fr/CD013344/RENAL_quelles-sont-les-interventions-qui-permettent-de-prevenir-ou-de-traiter-linfection-par-le-virus-bk
2024
United Kingdom
review of literature
french abstract
bk virus
infectious disease, nos
attentiveness
kidney transplantation
BK virus
kidney, nos
transplant, nos

---
https://www.has-sante.fr/jcms/p_3557612/fr/rapamune-sirolimus-lymphangioleiomyomatose-sporadique-s-lam
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
sirolimus
evaluation of the transparency committee
sirolimus
lymphangioleiomyomatosis

---
https://www.cbip.be/fr/articles/4448?folia=4434
2024
false
false
false
Belgium
French
pharmacovigilance note
journal article
cyclosporine
risk
fibroadenoma
premenopause

---
https://ansm.sante.fr/tableau-marr/enfortumab-vedotin
2024
false
false
false
France
French
risk management
enfortumab vedotin
enfortumab vedotin
drug information
patients guideline
Drug-Related side effects and adverse reactions
signs and symptoms
stevens-johnson syndrome
epidermal necrolysis, toxic
continuity of patient care

---
https://www.cochrane.org/fr/CD016278/CENTRALED_quels-sont-les-benefices-et-les-risques-de-lacide-tranexamique-pour-prevenir-les-saignements
2024
United Kingdom
review of literature
french abstract
acid, nos
cesarean section, nos
risk assessment
tranexamic acid
hemorrhage, nos
risks and benefits
bloodletting
attentiveness
cesarean section
hemorrhage
birth, nos
parturition

---
https://www.has-sante.fr/jcms/p_3562501/fr/prise-en-charge-therapeutique-du-patient-atteint-d-herpes-genital
2024
France
practice guideline
genital herpes simplex, nos
has patient
case management
disease
herpes genitalis
therapeutics

---
https://minerva-ebp.be/FR/Analysis/884
2024
Belgium
critical appraisal or critical reading
prostatism, nos
activir
prostate
disease, nos
fenestration, nos
watchful waiting
risk
snacks
disease
Diseases Category
prostate, nos
prostate symptom/complaint

---
https://www.santepubliquefrance.fr/regions/provence-alpes-cote-d-azur-et-corse/documents/enquetes-etudes/2024/observatoire-des-cancers-du-rein-de-la-vessie-et-des-leucemies-aigues-chez-l-adulte-dans-le-departement-des-bouches-du-rhone-revela13-.-analyses
2024
France
technical report
leukaemia
leukemia
kidney
mouth
spatial analysis
adult
urinary bladder
adulthood

---
https://www.cochrane.org/fr/CD014839/RENAL_pourquoi-est-il-important-dameliorer-le-diagnostic-de-la-nephropathie-associee-au-polyomavirus-bk
2024
United Kingdom
review of literature
french abstract
kidney disease, nos
polyomavirus, nos
no diagnosis
kidney diseases
diagnosis
BK virus
polyomavirus

---
https://www.cochrane.org/fr/CD014762/RENAL_les-anti-inflammatoires-non-steroidiens-sont-ils-efficaces-pour-traiter-les-infections-des-voies
2024
United Kingdom
review of literature
french abstract
urinary tract infectious disease, nos
urinary tract
anti-inflammatory agents, non-steroidal
urinary tract infections
women
urinary complication, nos
urinary tract infections
symptom, nos

---
https://www.chu-lyon.fr/cancer-de-la-prostate
2024
France
popular works
malignant neoplasm prostate
prostate, nos
neoplasm, malignant
prostate cancer
prostatic neoplasms
prostatism, nos

---
https://www.chu-lyon.fr/etp-en-jeux-greffe-patient-transplante-rein-ou-rein-pancreas
2024
France
popular works
patient education as topic
therapeutics
play and playthings
kidney
transplant of kidney, nos
transplant, nos
transplants
education
kidney transplantation
Program
has patient
patient care planning

---
https://www.chu-lyon.fr/etp-reins-qua-toi-programme-deducation-therapeutique
2024
France
popular works
patient care planning
education
kidney
Program
patient education as topic
therapeutics

---
https://www.chu-lyon.fr/hypertrophie-benigne-de-prostate-adenome-de-prostate
2024
France
popular works
prostatic hyperplasia
adenoma, prostatic
prostatic hypertrophy, benign
adenoma
benign prostatic hypertrophy
benign adenoma of prostate
hyperplasia of prostate, nos

---
https://www.chu-lyon.fr/medicaments-contre-les-troubles-de-lerection-ipde5
2024
France
popular works
drug, nos
erectile dysfunction
phosphodiesterase 5 inhibitors
pharmaceutical preparations

---
https://www.chu-lyon.fr/nephropathies-vasculaires
2024
France
popular works
kidney disease, nos
blood vessel, nos
kidney diseases

---
https://www.chu-lyon.fr/traitement-par-acide-tranexamique
2024
France
popular works
acid, nos
tranexamic acid

---
https://www.chu-lyon.fr/transplantation-renale-preparation-et-suivi-des-patients-porteurs-dune-greffe-de-rein
2024
France
popular works
kidney transplantation
transplant of kidney, nos
continuity of patient care
has patient
transplantation, nos
kidney, nos
kidney

---
https://www.has-sante.fr/jcms/p_3487172/fr/botox-toxine-botulinique-type-a-blepharospasme-spasme-hemifacial-torticolis-spasmodique
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
botulinum toxin
neuromuscular agents
evaluation of the transparency committee
hemifacial spasm
botulinum toxins, type A
blepharospasm
torticollis
Spasmodic Torticollis

---
https://www.has-sante.fr/jcms/p_3488172/fr/lynparza-olaparib-cancer-de-l-ovaire
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
olaparib
antineoplastic combined chemotherapy protocols
Bevacizumab/Olaparib Regimen
adult
Carcinoma, Ovarian Epithelial
Stage III Ovarian Cancer AJCC v6 and v7
Stage IV Ovarian Cancer AJCC v6 and v7
fallopian tube neoplasms
peritoneal neoplasms
administration, oral
evaluation of the transparency committee
olaparib

---
https://www.has-sante.fr/jcms/p_3492671/fr/altis
2024
France
health technology assessment
RELT wt Allele
Unique
suburethral slings
incision, nos
Ladd Band
Streak
Tryptophan 2,3-Dioxygenase
urethra, nos
Single
Urethral Dosage Form
Surgical Incision
Intraurethral Route of Administration
Strip Dosage Form
incisor
Treatment Environmental Setting
Single
Test Strip Device

---
https://www.has-sante.fr/jcms/p_3497035/fr/iopamiron-iopamidol-produit-de-contraste-iode
2024
false
false
false
France
iopamidol
evaluation of the transparency committee
Iopamidol
iodine, nos
iopamidol
contrast media
iodine

---
https://www.has-sante.fr/jcms/p_3497017/fr/omnipaque-iohexol-produit-de-contraste-iode
2024
false
false
false
France
evaluation of the transparency committee
iodine
omnipaque
contrast media
iohexol

---
https://www.has-sante.fr/jcms/p_3497062/fr/iomeron-iomeprol-produit-de-contraste-iode
2024
false
false
false
France
evaluation of the transparency committee
iodine, nos
iomeprol
contrast media
iomeprol
Iomeprol
iomeron
iomeprol
iodine

---
https://www.has-sante.fr/jcms/p_3497026/fr/mircera-methoxy-polyethylene-glycol-epoetine-beta-anemie-symptomatique-associee-a-l-insuffisance-renale-chronique-chez-les-enfants-ages-de-3-mois-a-moins-de-18-ans
2024
false
false
false
France
infant
adolescent
treatment outcome
insurance, health, reimbursement
hematinics
methoxy polyethylene glycol-epoetin beta
Anemia of chronic renal failure (disorder)
evaluation of the transparency committee
continuous erythropoietin receptor activator
polyethylene glycols
anemia
erythropoietin
methoxy polyethylene glycol-epoetin beta
renal insufficiency, chronic
child

---
https://www.has-sante.fr/jcms/p_3497065/fr/visipaque-iodixanol-produit-de-contraste-iode
2024
false
false
false
France
iodixanol
-
-
evaluation of the transparency committee
iodine
iodixanol
contrast media

---
https://www.has-sante.fr/jcms/p_3497029/fr/xenetix-iobitridol-produit-de-contraste-iode
2024
false
false
false
France
iobitridol
evaluation of the transparency committee
contrast media
iodine
iobitridol

---
https://www.has-sante.fr/jcms/p_3498747/fr/radelumin-18f-psma-1007-cancer-de-la-prostate
2024
false
false
false
France
radiopharmaceuticals
insurance, health, reimbursement
Positron-Emission tomography
neoplasm staging
Prostate-Specific antigen
PSMA-1007 (18F)
evaluation of the transparency committee
prostatic neoplasms
PSMA-1007
Fluorine-18

---
https://www.has-sante.fr/jcms/p_3498744/fr/pylclari-18f-piflufolastat-cancer-de-la-prostate
2024
false
false
false
France
adult
radiopharmaceuticals
Positron-Emission tomography
F-18 DCFPyL PSMA Positron Emission Tomography
piflufolastat (18F)
Prostate-Specific antigen
neoplasm staging
neoplasm recurrence, local
injections, intravenous
evaluation of the transparency committee
prostatic neoplasms
Fluorine F 18 Piflufolastat
Fluorine-18

---
https://www.has-sante.fr/jcms/p_3498750/fr/keytruda-pembrolizumab-carcinome-a-cellules-renales
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
antineoplastic combined chemotherapy protocols
clear cell renal cell carcinoma
Lenvatinib/Pembrolizumab Regimen
Advanced Clear Cell Renal Cell Carcinoma
infusions, intravenous
Antineoplastic Agents, Immunological
pembrolizumab
evaluation of the transparency committee
pembrolizumab
carcinoma, renal cell

---
https://www.cochrane.org/fr/CD003962/RENAL_traitement-non-immunosuppresseur-dans-la-nephropathie-immunoglobulines
2024
United Kingdom
review of literature
french abstract
Nephropathy
Raw
IgA
kidney diseases
A^y/a
Immunoglobulin Therapy
immunoglobulin, nos
kidney disease, nos
immunosuppressive agents
Immunosuppressant
Intravenous Immunoglobulin Therapy
immunoglobulin A

---
https://www.inrs.fr/media.html?refINRS=TD%20309
2024
France
journal article
What Month is it
Post-Acute Sequelae of COVID-19
Thought Score 6
occupational health
occupation, nos
effects of exposure to external cause, nos
Scientist
kidney function tests
Smoking at Diagnosis
Illness Intrusiveness Rating 6
Occupational Health
respiratory function tests
Science
Fear Score 6
Post-Acute COVID-19 Syndrome
Severity of Symptom Score 6
Balance Sheet
Work-up
October
Six
health fairs
measurement of respiratory function, nos
Clinical Status Ordinal Scale Outcome 6

---
https://www.has-sante.fr/jcms/p_3500938/fr/ultravist-iopromide-produit-de-contraste-iode
2024
false
false
false
France
evaluation of the transparency committee
iopromide
iodine
contrast media

---
https://www.cfp.ca/content/70/3/e44
2024
Canada
journal article
Occur
Detection
urinary tract
Child Relation
Atropine/Hyoscyamine/Methenamine/Methylene Blue/Phenyl Salicylate/Benzoic Acid
Detached
symptom, nos
Urinary Tract Infection
child, nos
Israel
urinary tract infections
Child Individual
urinary tract infections
Interleukin
Symptom
syndrome
Deprecated
urinary tract infectious disease, nos
Illinois
child
Urinary Tract Infection, CTCAE
Detected

---
https://ansm.sante.fr/actualites/avis-de-lansm-du-11-03-2024-sur-le-medicament-keytruda-dans-le-cadre-dune-demande-daap
2024
false
false
false
France
French
treatment outcome
pembrolizumab
Antineoplastic Agents, Immunological
drug information
Resectable Lung Non-Small Cell Carcinoma
carcinoma, non-small-cell lung
neoplasm recurrence, local
risk
pembrolizumab

---
https://ansm.sante.fr/tableau-marr/belatacept
2024
false
false
false
France
French
guidelines for drug use
risk management
BELATACEPT
immunosuppressive agents
infusions, intravenous
belatacept
patient education handout
Infusion-Related Reaction
infusions, intravenous

---
https://www.cochrane.org/fr/CD014763/COLOCA_comparaison-de-deux-methodes-de-fermeture-de-la-plaie-dans-linversion-de-stomie-fermeture-par-cordon
2024
United Kingdom
review of literature
french abstract
XML Bound
Cutaneous
Binding
skin, nos
inversion
Enclosure Device
Fastener Device
Twice
Reversal
Stomatocyte Count
Comparison
Cord Device
Injury
Present
Inversion
EDQM-HC Closure Terminology
Wound
Pound
Technique
scrotum
wound, nos
protestantism
stoma site, nos
HNRNPM wt Allele
Cord
Stoma

---
https://www.has-sante.fr/jcms/p_3503151/fr/i-stop
2024
France
health technology assessment
Implant Dosage Form
Tryptophan 2,3-Dioxygenase
Implant Device Component
Stage I Cervical Cancer AJCC v8
Streak
Administration via Implantation
Stop
Ladd Band
Pathologic Stage I Esophageal Adenocarcinoma AJCC v8
suburethral slings
Iodide
Strip Dosage Form
urethra, nos
Stage I Bladder Cancer AJCC v8
Implant
Test Strip Device
Implanted Medical Device
Cease
Implant Dosage Form Category
ISS Stage I Multiple Myeloma
Retropubic
Treatment Environmental Setting
Stage I Intrahepatic Cholangiocarcinoma AJCC v8
RELT wt Allele
Inch
Clark Level I
Stage I Distal Bile Duct Cancer AJCC v8
Implantation
implant, nos
Intraurethral Route of Administration
MATCH Arm EAY131-I
Implanter Device
Stage I Hilar Cholangiocarcinoma AJCC v8
Stage I Prostate Cancer AJCC v8
Implant Dosing Unit
Iodine
Stage I Uveal Melanoma AJCC v7
Implantation Method of Administration

---
https://www.has-sante.fr/jcms/p_3506762/fr/balversa-erdafitinib-carcinome-urothelial
2024
false
false
false
France
erdafitinib
administration, oral
Product containing only erdafitinib in oral dose form (medicinal product form)
evaluation of the transparency committee
erdafitinib
erdafitinib
Erdafitinib

---
https://www.has-sante.fr/jcms/p_3508868/fr/acide-tranexamique-tillomed-acide-tranexamique-antifibrinolytique
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
injections, intravenous
adult
adolescent
child
hemorrhage
hemorrhage due to fibrinolysis
drugs, generic
tranexamic acid
evaluation of the transparency committee
antifibrinolytic agents
tranexamic acid

---
https://ansm.sante.fr/actualites/decision-du-25-04-2024-cadre-de-prescription-compassionnelle-de-botox-50-100-et-200-unites-allergan-poudre-pour-solution-injectable
2024
false
false
false
France
French
botulinum toxins, type A
drug information
neuralgia
Chronic peripheral neuropathic pain (finding)

---
https://ansm.sante.fr/tableau-acces-derogatoire/botox
2024
false
false
false
France
French
guidelines for drug use
botulinum toxins, type A
neuralgia
chronic disease
adult
Chronic peripheral neuropathic pain (finding)

---
https://www.has-sante.fr/jcms/p_3512093/fr/talzenna-talazoparib-cancer-de-la-prostate
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
antineoplastic combined chemotherapy protocols
Enzalutamide/Talazoparib Regimen
enzalutamide
metastatic castration resistant prostate cancer
adult
neoplasm metastasis
administration, oral
talazoparib
Poly(ADP-ribose) Polymerase Inhibitors
Product containing only talazoparib in oral dose form (medicinal product form)
evaluation of the transparency committee
talazoparib
prostatic neoplasms, Castration-Resistant

---
https://www.has-sante.fr/jcms/p_3516751/fr/akeega-niraparib/acetate-d-abiraterone-cancer-de-la-prostate
2024
false
false
false
France
evaluation of the transparency committee
abiraterone
prostatism, nos
Prostate Carcinoma
prostatic neoplasms
Prostate Cancer pT2c TNM Finding v6 and v7
NCI CTEP SDC Prostate Cancer Sub-Category Terminology
Prostate Cancer Pathway
prostate cancer
neoplasm, malignant
prostate, nos
Abiraterone
abiraterone
malignant neoplasm prostate

---
https://www.cochrane.org/fr/CD006124/RENAL_chirurgie-coelioscopique-laparoscopique-comparee-traditionnelle-ouverte-chez-les-donneurs-de-rein
2024
United Kingdom
review of literature
french abstract
laparoscopes
Laparoscopic Surgery
Comparator
donor of kidney for transplant
Open
kidney
laparoscope
operative procedure, nos
Comparator Device
laparoscopy, nos
tissue donors
laparoscopy
Comparison
Kidney Donor
donors

---
https://www.has-sante.fr/jcms/p_3517160/fr/tecentriq-atezolizumab-oncologie
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
Product containing only atezolizumab in parenteral dose form (medicinal product form)
atezolizumab
antineoplastic combined chemotherapy protocols
Atezolizumab/Bevacizumab/Carboplatin/Paclitaxel Regimen
neoplasm metastasis
carcinoma, non-small-cell lung
small cell lung carcinoma
Extensive Stage Lung Small Cell Carcinoma
antineoplastic agents
Unresectable Hepatocellular Carcinoma
Advanced Hepatocellular Carcinoma
carcinoma, hepatocellular
evaluation of the transparency committee
atezolizumab

---
https://www.has-sante.fr/jcms/p_3517560/fr/soliris-eculizumab-myasthenie
2024
false
false
false
France
eculizumab
generalised myasthenia gravis with anti-acetylcholine receptor antibody
treatment outcome
child
Acetylcholine receptor antibody (substance)
infusions, intravenous
evaluation of the transparency committee
eculizumab
myasthenia gravis

---
https://www.has-sante.fr/jcms/p_3517166/fr/genotonorm-somatropine-hormone-de-croissance
2024
false
false
false
France
failure to thrive
evaluation of the transparency committee
Somatropin
hormone, nos
human growth hormone
growth hormone
Somatotropin

---
https://ansm.sante.fr/actualites/decision-dautorisation-dimportation-parallele-accordee-le-05-10-2023-triflucan-40-mg-ml-poudre-pour-suspension-buvable
2023
false
false
false
France
French
legislation
drug information
administration, oral

---
https://www.has-sante.fr/jcms/p_3262788/fr/antibiogrammes-cibles-pour-les-infections-urinaires-a-enterobacteries-dans-la-population-feminine-adulte-a-partir-de-12-ans
2023
France
practice guideline
health services needs and demand
urinary tract infectious disease, nos
microbial sensitivity tests
target population
adult
enterobacteriaceae infections
Target Study Population
Twelve
adulthood
Autonomic Nervous System
urinary tract infections
Urinary Tract Infection
antibiogram
Estradiol Acetate
Feminine
Legal Adult
Algeria
urinary tract infections
female, nos

---
https://publications.msss.gouv.qc.ca/msss/document-003639/
2023
Canada
handbooks
Phenylmercuric Acetate
complication, nos
Treatment Environmental Setting
Complication
female
critical pathways
RELT wt Allele
Streak
suburethral slings
urethra, nos
Ladd Band
nursing
women
Wife
Test Strip Device
Estrogens, Conjugated
Care Of
Urethral Dosage Form
Tryptophan 2,3-Dioxygenase
Oman
Strip Dosage Form
Woman
Intraurethral Route of Administration
Female Phenotype

---
https://kce.fgov.be/fr/publications/diagnostic-et-prise-en-charge-de-la-gonorrhee-et-de-la-syphilis
2023
Belgium
technical report
french abstract
Syphilis
Diagnosis Code
Date of Diagnosis
gonorrhea
Charge
diagnosis
Gonorrhea
Diagnosis Study
no diagnosis
syphilis, nos
gonorrhea, nos
patient care management
syphilis

---
https://www.cochrane.org/fr/CD001321/RENAL_les-canneberges-dans-la-prevention-des-infections-urinaires
2023
United Kingdom
review of literature
french abstract
urinary tract infections
urinary tract infectious disease, nos
infection control
vaccinium macrocarpon
cranberry
Cranberry
Prevention Study
Prevention
Preventive Intervention
Urinary Tract Infection
urinary tract infections

---
https://www.has-sante.fr/jcms/p_3470390/fr/ibiron-abiraterone-cancer-de-la-prostate
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
Abiraterone Acetate
abiraterone
administration, oral
antineoplastic agents
antineoplastic combined chemotherapy protocols
metastatic castration resistant prostate cancer
neoplasm metastasis
adult
evaluation of the transparency committee
prostatic neoplasms

---
https://www.has-sante.fr/jcms/p_3470393/fr/bavencio-avelumab-carcinome-a-cellules-de-merkel
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
infusions, intravenous
Antineoplastic Agents, Immunological
avelumab
evaluation of the transparency committee
carcinoma, merkel cell
avelumab

---
https://www.has-sante.fr/jcms/p_3471813/fr/erleada-apalutamide-cancer-de-la-prostate
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
Product containing only apalutamide in oral dose form (medicinal product form)
apalutamide
androgen receptor antagonists
Hormone-sensitive prostate cancer metastatic
Hormone sensitive prostate cancer (disorder)
evaluation of the transparency committee
apalutamide
prostatic neoplasms, Castration-Resistant

---
https://www.has-sante.fr/jcms/p_3474603/fr/pylclari-18f-piflufolastat-cancer-de-la-prostate
2023
false
false
false
France
insurance, health, reimbursement
Fluorine F 18 Piflufolastat
piflufolastat (18F)
radiopharmaceuticals
Positron-Emission tomography
F-18 DCFPyL PSMA Positron Emission Tomography
neoplasm recurrence, local
neoplasm staging
injections, intravenous
evaluation of the transparency committee
prostatic neoplasms
Fluorine-18

---
https://www.cochrane.org/fr/CD007044/PROSTATE_le-traitement-par-ondes-de-choc-est-il-plus-efficace-que-les-procedures-chirurgicales-pour-eliminer
2023
false
false
false
United Kingdom
kidney calculi
kidney calculi
treatment outcome
review of literature
french abstract
nephrostomy, percutaneous
lithotripsy
kidney calculi

---
https://www.has-sante.fr/jcms/p_3323646/fr/label-bilans-pre-therapeutiques-des-troubles-mictionnels-de-l-homme-adulte-modalites-et-acteurs
2023
France
guideline
Balance Sheet
humans
Therapeutic Procedure
Therapeutic
Legal Adult
PITRM1 wt Allele
Tracer
homo sapiens
Male
Treatment
adulthood
Label Device
Medical Product Label
Human Cells, Tissues, and Cellular and Tissue-Based Products Labeling
ELL wt Allele
Checkup
Man Chinese
Grassland
Disease or Disorder
Bile Pigment
adult
Man
actor
Labeling Activity
therapeutics
urination disorders
Mandinka Language

---
https://www.has-sante.fr/jcms/p_3476380/fr/vecalmys-succinate-de-solifenacine-/-chlorhydrate-de-tamsulosine-troubles-urologiques
2023
false
false
false
France
administration, oral
drug combinations
treatment outcome
insurance, health, reimbursement
tamsulosin and solifenacin
urinary incontinence, urge
Urinary Frequency
Enlarged Prostate with Lower Urinary Tract Symptoms
prostatic hyperplasia
urological agents
evaluation of the transparency committee
tamsulosin hydrochloride
Tamsulosin
Solifenacin Succinate

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/usage-optimal-des-traitements-dune-infection-urinaire-chez-les-personnes-de-14-ans-et-plus.html
2023
Canada
practice guideline
Trait
Treat
urinary tract infections
persons
urinary tract infectious disease, nos
On Treatment
Therapy Object
Usage
Treatment Epoch
Treatment
Optimum
Tray Dosing Unit
More
Treating
Urinary Tract Infection
urinary tract infections
Treatment Study
Biomaterial Treatment
During Treatment
People
Autonomic Nervous System
Tray
No Treatment for Diabetes
GDC Treatment Frequency Terminology
Fourteen

---
https://www.has-sante.fr/jcms/p_3477519/fr/destruction-par-ultrasons-focalises-de-haute-intensite-hifu-par-voie-rectale-d-un-adenocarcinome-localise-de-la-prostate-rapport-d-evaluation
2023
France
health technology assessment
Rectal Adenocarcinoma
evaluation report
rectum, nos
prostate symptom/complaint
Ratio
Physical Examination
Focus
Destruction
albumin/globulin ratio
prostate, nos
evaluation studies as topic
Adenocarcinoma of the Rat Rectum
Regulatory Report
administration, rectal
Assessment
High-Intensity Focused Ultrasound Ablation
Assessment
adenocarcinoma
Rectal Route of Administration
Ultrasonic Waves
Locally Advanced Prostate Adenocarcinoma
prostatism, nos
Evaluation
ultrasonics
prostate
Intensity

---
https://www.has-sante.fr/jcms/p_3477070/fr/nubeqa-darolutamide-cancer-de-la-prostate-hormonosensible-metastatique-cphsm
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
antineoplastic combined chemotherapy protocols
Docetaxel
androgen receptor antagonists
Hormone-sensitive prostate cancer metastatic
neoplasm metastasis
Hormone sensitive prostate cancer (disorder)
adult
darolutamide
Darolutamide/Docetaxel Regimen
evaluation of the transparency committee
prostatic neoplasms
darolutamide

---
https://www.has-sante.fr/jcms/p_3477569/fr/padcev-enfortumab-vedotin-carcinome-urothelial
2023
France
evaluation of the transparency committee
enfortumab vedotin
enfortumab vedotin
carcinoma
Urothelial Carcinoma
Enfortumab Vedotin

---
https://www.has-sante.fr/jcms/p_3477883/fr/akeega-niraparib/-acetate-d-abiraterone-cancer-de-la-prostate
2023
false
false
false
France
niraparib and abiraterone
insurance, health, reimbursement
treatment outcome
niraparib
drug combinations
Poly(ADP-ribose) Polymerase Inhibitors
antineoplastic agents
antineoplastic combined chemotherapy protocols
metastatic castration-resistant prostate cancer and BRCA 1/2 mutations in whom chemotherapy is not clinically indicated
neoplasm metastasis
administration, oral
evaluation of the transparency committee
Abiraterone Acetate
prostatic neoplasms

---
https://www.has-sante.fr/jcms/p_3475940/fr/luja-homme
2023
France
health technology assessment
urinary catheters
Binary
Probe Device
Male
Urinary
ELL wt Allele
probing, nos
Tube Device
urinary catheterization
catheterization
humans
Man
urinary catheter
homo sapiens
Tube Dosing Unit
Man Chinese
Murine Urinary System
Tracheostomy Tube
Chemical Probe
Mandinka Language

---
https://www.has-sante.fr/jcms/p_3483677/fr/biopsies-ciblees-dans-le-diagnostic-du-cancer-de-la-prostate-rapport-d-evaluation
2023
France
health technology assessment
diagnosis
Prostate Cancer Pathway
Assay Target Antigen
Prostate Carcinoma
Biopsy of Prostate
prostatic neoplasms
malignant neoplasm prostate
prostate cancer
evaluation studies as topic
NCI CTEP SDC Prostate Cancer Sub-Category Terminology
prostate biopsy
biopsy
biopsy of prostate, nos
no diagnosis
Cancer Diagnosis
neoplasm, malignant
Prostate Cancer pT2c TNM Finding v6 and v7

---
https://dumas.ccsd.cnrs.fr/dumas-04346650
2023
France
dissertations, academic
Primary Care
prostatism, nos
early detection of cancer
No Information Available
cancer screening
tool, nos
prostate cancer
Data Set
patient participation
Placement
screening for cancer
Data
prostatic neoplasms
Reviewing
Screening for Prostate Cancer
principal
primary health care
Shared
classification
Share
Tool
review literature as topic
dataset
malignant neoplasm prostate
nursing
Systematic Review
Actual
Scientific Equipment
prostate, nos
primary health care

---
https://www.medix.ch/fr/connaissances/guide-des-bonnes-pratiques/infections-des-voies-urinaires-enfants/
2023
Switzerland
practice guideline
Urinary Tract Infection
Offspring
urinary tract infections
urinary tract infections
Child
urinary tract
child
child, nos
Urinary System
urinary tract infectious disease, nos

---
https://www.canada.ca/fr/sante-publique/services/maladies-infectieuses/sante-sexuelle-infections-transmissibles-sexuellement/lignes-directrices-canadiennes/gonorhee.html
2023
Canada
guideline
health resources
Information Resource
Gonorrhea
Importer
gonorrhea
Import
gonorrhea, nos
information resources

---
https://dumas.ccsd.cnrs.fr/dumas-04550998
2023
France
dissertations, academic
primary health care
Acute Interstitial Pneumonia
Erectile Dysfunction, CTCAE
AH Receptor-Interacting Protein
functional disorder, nos
principal
Scientific Equipment
Line Unit of Length
primary health care
Without Help
Charge
erectile dysfunction
Primary Care
Male Erectile Disorder
tool, nos
Single-Stranded DNA Cytosine Deaminase
Caregiver Burden
With Some Help
Tool
nursing
Long Interspersed Element
Atherogenic Index of Plasma
AIP Gene
Ligne
Assistance
AICDA wt Allele

---
https://www.ema.europa.eu/en/medicines/human/EPAR/locametz
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Gozetotide
Gozetotide
drug approval
europe
Positron-Emission tomography
diagnostic uses of chemicals
gallium 68 PSMA-11
prostatic neoplasms
adult
gallium radioisotopes
radiopharmaceuticals
injections, intravenous
FOLH1 protein, human
gallium (68Ga) gozetotide
product surveillance, postmarketing
Radiopharmaceutical Preparation Kit Dosage Form
pregnancy
breast feeding

---
https://www.ema.europa.eu/en/medicines/human/EPAR/pluvicto
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
radiopharmaceuticals
Lutetium Lu 177 Vipivotide Tetraxetan
Lutetium Lu 177 Vipivotide Tetraxetan
lutetium (177Lu) vipivotide tetraxetan
radiopharmaceuticals
radiopharmaceuticals
Lutetium-177
prostatic neoplasms, Castration-Resistant
neoplasm metastasis
PSMA-Positive Tumor
antineoplastic combined chemotherapy protocols
injections, intravenous
infusions, intravenous
FOLH1 protein, human
product surveillance, postmarketing
pregnancy
breast feeding

---
https://www.ceredih.fr/uploads/CEREDIH_RECO_ANTIBIO_2022_12_16.pdf
2023
France
scientific and technical information
amoxicillin-potassium clavulanate combination
Cefpodoxime
cefpodoxime
has patient
immunologic deficiency syndromes
France
bactrim
cefpodoxime
clamoxyl
France
France
patients
disease
clavulanic acid
france
augmentin
research report
french
albumin/globulin ratio
Cefpodoxime Proxetil
tension
France
amoxycillin with clavulanate potassium
Primary Immunodeficiency Diseases
amoxicillin
primary immune deficiency disorder, nos

---
https://www.has-sante.fr/jcms/p_3406124/fr/tecentriq-atezolizumab-cancer-bronchique-non-a-petites-cellules-cbnpc
2023
false
false
false
France
evaluation of the transparency committee
Tecentriq
neoplasm, malignant
"u" lymphocyte
cancer
atezolizumab
due to
Cancer
atezolizumab
bronchus, nos
Cell
carcinoma, non-small-cell lung
cells

---
https://www.cfp.ca/content/69/1/e14
2023
Canada
journal article
aged, 80 and over
kidney diseases
Chronic kidney disease
elderly person, nos
aged
kidney disease, nos

---
https://www.urofrance.org/formation/nephrectomie-partielle-robotique/
2023
France
audiovisual aids
partial nephrectomy
robotics
robot
nephrectomy
Robotics

---
https://www.has-sante.fr/jcms/p_3411344/fr/lynparza-olaparib-cancer-du-sein-precoce-a-haut-risque-her2-negatif
2023
false
false
false
France
Early Stage HER2-Negative Breast Carcinoma
HER2/Neu Negative
High Risk Breast Carcinoma
breast neoplasms
mutation
treatment outcome
insurance, health, reimbursement
Germline BRCA1 Gene Mutation
Germline BRCA2 Gene Mutation
administration, oral
olaparib
evaluation of the transparency committee
olaparib
breast neoplasms
risk

---
https://www.has-sante.fr/jcms/p_3395770/fr/keytruda-pembrolizumab-melanome-de-stade-iib-iic-ou-iii
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
adolescent
Stage IIB Cutaneous Melanoma AJCC v6 and v7
Stage IIC Cutaneous Melanoma AJCC v6 and v7
melanoma
Stage III Cutaneous Melanoma AJCC v7
Advanced Cutaneous Melanoma
infusions, intravenous
Antineoplastic Agents, Immunological
evaluation of the transparency committee
melanoma
pembrolizumab

---
https://www.has-sante.fr/jcms/p_3418559/fr/i-stop
2023
France
health technology assessment
implant, nos
suburethral slings
urethra, nos

---
https://www.has-sante.fr/jcms/p_3422180/fr/urorec-silodosine-hypertrophie-benigne-de-la-prostate
2023
false
false
false
France
insurance, health, reimbursement
silodosin
administration, oral
evaluation of the transparency committee
prostatic hyperplasia
prostatic hypertrophy, benign
silodosin

---
https://ansm.sante.fr/informations-de-securite/kits-optiject-risque-de-fissure-au-niveau-de-la-connexion-entre-la-seringue-et-la-tubulure-dinjection-de-produit-de-contraste
2023
false
false
false
France
French
pharmacovigilance note
contrast media
risk
Device cracked
ioversol
ioversol

---
http://manuel3.cuen.fr/spip.php?rubrique11
2023
false
false
false
France
educational course
French pre-residency program examination
Proteinuria
proteinuria
nephrotic syndrome
nephrotic syndrome, nos
proteinuria syndrome, nos
Nephrotic syndrome

---
http://manuel3.cuen.fr/spip.php?rubrique15
2023
false
false
false
France
educational course
French pre-residency program examination
Systemic disease
Diseases
Kidney
kidney disease, nos
Gold-193
kidney diseases
systemic disease, nos

---
http://manuel3.cuen.fr/spip.php?rubrique21
2023
false
false
false
France
educational course
French pre-residency program examination
kidney diseases
Nephropathy
kidney disease, nos
blood vessel, nos

---
http://manuel3.cuen.fr/spip.php?rubrique24
2023
false
false
false
France
educational course
French pre-residency program examination
Urinary tract infection
Adult
Child
Child
adulthood
Adult
Child
child
adult children
urinary tract infectious disease, nos
child, nos
urinary tract infections
urinary tract infections
adult
Child

---
http://manuel3.cuen.fr/spip.php?rubrique25
2023
false
false
false
France
educational course
French pre-residency program examination
Urinary lithiasis
urinary calculus
urolithiasis
Urinary lithiasis
urolithiasis, nos
lithiasis

---
http://manuel3.cuen.fr/spip.php?article115
2023
France
educational course
French pre-residency program examination
kidney disease, nos
fracture fixation
classification
Nephropathy
kidney diseases

---
https://www.has-sante.fr/jcms/p_3425643/fr/lynparza-olaparib-cancer-de-la-prostate
2023
false
false
false
France
antineoplastic combined chemotherapy protocols
treatment outcome
insurance, health, reimbursement
abiraterone
prednisone
prednisolone
neoplasm metastasis
adult
metastatic castration resistant prostate cancer
olaparib
antineoplastic agents
guidelines for drug use
administration, oral
evaluation of the transparency committee
olaparib
prostatic neoplasms

---
https://www.has-sante.fr/jcms/p_3427326/fr/vapro-pocket
2023
France
health technology assessment
urinary catheter
catheterization
urinary catheters
urinary catheterization
probing, nos

---
https://www.has-sante.fr/jcms/p_3427329/fr/vapro-plus-pocket
2023
France
health technology assessment
probing, nos
urinary catheter
urinary catheterization
catheterization
urinary catheters

---
https://www.urofrance.org/2023/05/02/cystite-recidivante-du-depistage-a-la-prise-en-charge-optimale-2/
2023
France
scientific and technical information
cystitis, nos
Recidivism
cystitis
patient care management
recurrent
mass screening
Cystitis
screening

---
https://www.has-sante.fr/jcms/p_3428422/fr/locametz-gozetotide-cancer-de-la-prostate
2023
false
false
false
France
insurance, health, reimbursement
Gozetotide
Radiopharmaceutical Preparation Kit Dosage Form
gallium (68Ga) gozetotide
radiopharmaceuticals
gallium 68 PSMA-11
adult
Positron-Emission tomography
FOLH1 protein, human
evaluation of the transparency committee
prostatic neoplasms

---
https://www.has-sante.fr/jcms/p_3427913/fr/soliris-eculizumab-syndrome-hemolytique-et-uremique-atypique-shua
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
eculizumab
infusions, intravenous
adult
child
evaluation of the transparency committee
Atypical Hemolytic Uremic Syndrome
eculizumab

---
https://ansm.sante.fr/informations-de-securite/simulect-10-mg-et-simulect-20-mg-poudre-et-solvant-pour-solution-injectable-ou-pour-perfusion-ne-pas-utiliser-les-ampoules-de-solvant-eau-pour-preparations-injectables-eau-ppi-conditionnees-avec-les-flacons
2023
false
false
false
France
French
pharmacovigilance note

---
https://www.has-sante.fr/jcms/p_3433922/fr/talzenna-talazoparib-cancer-de-la-prostate
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
talazoparib
talazoparib
Poly(ADP-ribose) Polymerase Inhibitors
metastatic castration resistant prostate cancer
prostatic neoplasms, Castration-Resistant
neoplasm metastasis
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3434157/fr/orgovyx-relugolix-cancer-de-la-prostate-avance-hormonodependant
2023
false
false
false
France
orgovyx
neoplasms, hormone-dependent
treatment outcome
insurance, health, reimbursement
advanced hormone-dependent prostate cancer
adult
Product containing precisely relugolix 120 milligram/1 each conventional release oral tablet (clinical drug)
administration, oral
relugolix
androgen antagonists
evaluation of the transparency committee
relugolix
prostatic neoplasms

---
https://dumas.ccsd.cnrs.fr/dumas-04069207
2023
France
screening for cancer
emigration and immigration
prostate cancer
prostatism, nos
Records
prostate, nos
Literature
review literature as topic
prostatic neoplasms
early detection of cancer
cancer screening
consumer health information
readability
comprehension
Prostate cancer
malignant neoplasm prostate
patient given information

---
https://www.has-sante.fr/jcms/p_3434800/fr/dysport-500-unites-speywood-toxine-botulinique-type-a-blepharospasme-spasme-hemifacial-torticolis-spasmodique
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
neuromuscular agents
botulinum toxin
evaluation of the transparency committee
torticollis
blepharospasm
hemifacial spasm
botulinum toxins, type A

---
https://www.inspq.qc.ca/publications/3330
2023
Canada
technical report
reticulum
quebec
drug resistance, microbial
treatment failure
Gonococcal infection
gonorrhea, nos
gonorrhea
sentinel surveillance
resulting in

---
https://www.inspq.qc.ca/publications/3331
2023
Canada
technical report
Gonococcal infection
treatment failure
drug resistance, microbial
gonorrhea
reticulum
quebec
resulting in
sentinel surveillance
gonorrhea, nos

---
https://www.has-sante.fr/jcms/p_3443283/fr/pluvicto-lutecium-177lu-vipivotide-tetraxetan-cancer-de-la-prostate
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
radiopharmaceuticals
Lutetium Lu 177 Vipivotide Tetraxetan
lutetium (177Lu) vipivotide tetraxetan
adult
neoplasm metastasis
metastatic castration resistant prostate cancer
evaluation of the transparency committee
prostatic neoplasms, Castration-Resistant
lutetium

---
https://ansm.sante.fr/actualites/avis-de-lansm-du-13-04-2023-sur-le-medicament-talzenna-dans-le-cadre-dune-demande-daap
2023
false
false
false
France
French
drug information
administration, oral
talazoparib
talazoparib
Poly(ADP-ribose) Polymerase Inhibitors
adult
antineoplastic combined chemotherapy protocols
enzalutamide
prostatic neoplasms, Castration-Resistant
neoplasm metastasis
metastatic castration resistant prostate cancer

---
https://ansm.sante.fr/tableau-acces-derogatoire/talazoparib-0-25-mg-gelule
2023
false
false
false
France
French
talazoparib
drug information

---
https://www.ema.europa.eu/en/medicines/human/EPAR/akeega
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
drug approval
europe
Abiraterone Acetate/Niraparib
Abiraterone Acetate/Niraparib
Abiraterone Acetate
Abiraterone Acetate
niraparib
niraparib
antineoplastic agents
antineoplastic agents
neoplasm metastasis
prostatic neoplasms, Castration-Resistant
metastatic castration resistant prostate cancer
prostatic neoplasms, Castration-Resistant
adult
drug therapy, combination
prednisone
BRCA1 Gene Mutation
BRCA2 Gene Mutation
administration, oral
Poly(ADP-ribose) Polymerase Inhibitors
Poly(ADP-ribose) Polymerase Inhibitors
Poly (ADP-Ribose) Polymerase-1
PARP2 protein, human
Cytochrome P-450 Enzyme Inhibitors
Cytochrome P-450 Enzyme Inhibitors
steroid 17-alpha-hydroxylase
drug interactions
fertility
pregnancy
breast feeding
niraparib and abiraterone
drug evaluation, preclinical
metastatic castration-resistant prostate cancer and BRCA 1/2 mutations in whom chemotherapy is not clinically indicated

---
https://www.has-sante.fr/jcms/p_3396878/fr/keytruda-pembrolizumab-cancer-du-sein-triple-negatif
2023
false
false
false
France
triple negative breast neoplasms
treatment outcome
insurance, health, reimbursement
Antineoplastic Agents, Immunological
pembrolizumab
antineoplastic combined chemotherapy protocols
infusions, intravenous
Locally Advanced Triple-Negative Breast Carcinoma
Early Stage Triple-Negative Breast Carcinoma
locally advanced triple negative breast cancer at high risk of recurrence
early stage triple negative breast cancer at high risk of recurrence
evaluation of the transparency committee
pembrolizumab

---
https://www.has-sante.fr/jcms/p_3409403/fr/keytruda-pembrolizumab-carcinome-a-cellule-renale
2023
false
false
false
France
chemotherapy, adjuvant
treatment outcome
insurance, health, reimbursement
pembrolizumab
infusions, intravenous
Antineoplastic Agents, Immunological
clear cell renal cell carcinoma
nephrectomy
clear cell renal cell carcinoma
renal cell carcinoma at increased risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions
evaluation of the transparency committee
pembrolizumab
carcinoma, renal cell

---
https://www.has-sante.fr/jcms/p_3445464/fr/tadalafil-zentiva-tadalafil-dysfonction-erectile
2023
false
false
false
France
evaluation of the transparency committee
functional disorder, nos
Tadalafil
erectile dysfunction

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/protocole-medical-national-infections-urinaires.html
2023
Canada
review of literature
elderly person, nos
weights and measures
Urinary tract infection
measures
pharmacology
cystitis, nos
symptom, nos
signs and symptoms
urinary tract infections
Symptom
administration, oral
diagnosis
cystitis
Pyelonephritis
aged, 80 and over
pharmacologist
pyelonephritis, nos
suggestion
aged
pyelonephritis
intention
urinary tract infections
Cystitis
urinary tract infectious disease, nos

---
https://minerva-ebp.be/FR/Article/2329
2023
Belgium
critical appraisal or critical reading
urinary tract infections
urinary tract infections
pyuria
Urinary tract infection
urinary tract infectious disease, nos
pyuria
no diagnosis
diagnosis

---
https://www.has-sante.fr/jcms/p_3456515/fr/nulojix-belatacept-prevention-du-rejet-de-greffon-renal
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug therapy, combination
adult
kidney transplantation
infusions, intravenous
belatacept
mycophenolic acid
glucocorticoids
evaluation of the transparency committee
BELATACEPT
Abatacept
graft rejection

---
https://ansm.sante.fr/informations-de-securite/ketamine-une-utilisation-prolongee-entraine-des-atteintes-graves-hepatiques-et-uronephrologiques
2023
false
false
false
France
French
pharmacovigilance note
ketamine
kidney diseases
Drug-Induced Liver Disease
cystitis
narcotics
prescription drug misuse
guidelines for drug use
Long-Term
Off-Label use
biliary tract diseases

---
https://www.has-sante.fr/jcms/p_3455982/fr/bip-foley-catheter
2023
France
health technology assessment
Murine Urinary System
urinary catheters
foley catheter
BIP Regimen
Binary
Urinary
urinary catheterization
Catheter
Pager
catheterization
Foley Catheter
Bone Morphogenetic Protein 3B
Permanent
urinary catheter
Bronchoalveolar Biopsy Specimen
catheter, nos
78 kDa Glucose-Regulated Protein
Balloon Device
probing, nos

---
https://www.has-sante.fr/jcms/p_3457949/fr/bip-foley-catheter-silicone-et-bip-foley-tiemann
2023
false
false
false
France
health technology assessment
urinary catheterization
urinary catheters

---
https://www.has-sante.fr/jcms/p_3460127/fr/lift
2023
France
health technology assessment
Implant Dosage Form
Treatment Environmental Setting
Implant Device Component
Implantation Method of Administration
Tryptophan 2,3-Dioxygenase
urethra, nos
Streak
Administration via Implantation
Intraurethral Route of Administration
Strip Dosage Form
suburethral slings
Implantation
RELT wt Allele
Test Strip Device
Implant Dosage Form Category
Implanter Device
Implant Dosing Unit
Ladd Band
Implant
Retropubic
Implanted Medical Device
implant, nos

---
https://minerva-ebp.be/FR/Analysis/832
2023
Belgium
critical appraisal or critical reading
Nonclinical Randomization
choice behavior
Localized Malignant Neoplasm
case study
malignant neoplasm prostate
Locally Advanced Malignant Neoplasm
prostatic neoplasms
Cancer Risk
prostate cancer
survival
general surgery
neoplasm, malignant
International Prognostic Index Low Risk Group
American College of Cardiology/American Heart Association Lesion Complexity Score A
resulting in
Long-Term
Prostate Cancer Outcomes Study
radiotherapy
Drug Accumulation 1.2 to 1.99
asthenia
activir
Similarity
Patient Observation
operative procedure, nos
snacks
watchful waiting
Case Series
risk
sampling studies
Case Study
IPSS-R Risk Category Low
radiation therapy, nos
Low Risk
outcome studies
Therapeutic Skin Surgery
X-ray Therapy
prostate, nos
Disease Risk Index Low Risk
Choose
Cancer Survivorship Research
therapeutics

---
https://www.ema.europa.eu/en/medicines/human/EPAR/pylclari
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Fluorine F 18 Piflufolastat
Fluorine F 18 Piflufolastat
piflufolastat (18F)
drug approval
europe
adult
prostatic neoplasms
Positron-Emission tomography
FOLH1 protein, human
neoplasm recurrence, local
Presence of direct invasion by primary malignant neoplasm of prostate to periprostatic tissue (observable entity)
neoplasm staging
fluorine radioisotopes
fluorine radioisotopes
radiopharmaceuticals
product surveillance, postmarketing
injections, intravenous
pregnancy
breast feeding
drug evaluation, preclinical

---
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2023-49/issue-9-september-2023/ccdrv49i09a04af-fra.pdf
2023
Canada
scientific and technical information
Genetic Screening
Last Screening
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
gonorrhea
pregnancy
Substance Screening
chlamydia, nos
Pregnancy
gonorrhea, nos
Cancer Screening
Site Screening
health planning guidelines
Gonorrhea
chlamydia
Working Kelpie
Screening Study
Eligibility Determination
screening
canada
Chlamydia
pregnancy, nos
Chlamydial Infection
Chlamydia Measurement
Trial Screening
mass screening
Pregnant

---
https://www.cancer.fr/catalogue-des-publications/la-biopsie-de-la-prostate
https://www.cancer.fr/personnes-malades/diagnostic/examens/la-biopsie/biopsie-de-la-prostate
2023
false
false
false
France
patient education handout
Biopsy of Prostate
biopsy
prostate symptom/complaint
prostate
biopsy of prostate, nos
prostate biopsy

---
https://www.ssmg.be/wp-content/uploads/RMG/402/RMG402_06-10.pdf
2023
France
journal article
urinary tract infections
indwelling urinary catheter
has patient
Tube Dosing Unit
Tube Device
Probe Device
case management
Patient Load
urinary catheter
Urinary Tract Infection
Chemical Probe
Tracheostomy Tube
urinary tract infections
urinary tract infectious disease, nos
catheters, indwelling
urinary catheters

---
https://www.who.int/fr/news-room/fact-sheets/detail/gonorrhoea-(neisseria-gonorrhoeae-infection)
2023
Switzerland
scientific and technical information
popular works
Adverse Event Associated with Infection
Neisseria gonorrhoeae Measurement
Infection
Neisseria gonorrhoeae
neisseria gonorrhoeae
gonorrhea
Gonorrhea
gonorrhea, nos

---
Summary Safety Review - Keytruda (pembrolizumab) and Tecentriq (atezolizumab) - Assessing the Potential Risk of Aplastic Anemia
https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1691503886633
2023
false
false
false
Canada
French
drug evaluation
Drug-Related side effects and adverse reactions
pembrolizumab
antibodies, monoclonal, humanized
atezolizumab
Antineoplastic Agents, Immunological
risk assessment
anemia, aplastic
Immune Checkpoint Inhibitors
canada
pharmacovigilance note

---
https://www.liguecancer.ch/a-propos-du-cancer/depistage/cancer-de-la-prostate
2022
false
Switzerland
French
video recording
prostatic neoplasms
mass screening
popular works

---
https://www.ameli.fr/assure/sante/themes/cancer-prostate
2022
true
France
French
popular works
prostatic neoplasms
risk factors
signs and symptoms
prostatic neoplasms
prostatic neoplasms
mass screening

---
https://www.chu-lyon.fr/prostatectomie-ablation-de-la-prostate
2022
France
popular works
prostatectomy
prostate, nos
prostatism, nos
excision, nos
prostatectomy, nos
prostate symptom/complaint
prostate

---
https://dumas.ccsd.cnrs.fr/dumas-04043312
2022
France
dissertations, academic
midwives
France
politics
France
France
midwifery
france
Infectious disease
gonorrhea, nos
France
french
mass screening
chlamydia infections
neisseria gonorrhoeae
adolescent
screening
liberalism

---
Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.